Supplement × Prescription·contraindicated·Moderate evidence

L-Tryptophan + Rasagiline

Contraindicated Moderate evidence

L-Tryptophan supplementation increases serotonin precursor availability during MAO-B inhibitor therapy.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances
Pair type
Contraindicated
Evidence
Moderate
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
ContraindicatedModerate evidence

What is happening. L-Tryptophan supplementation increases serotonin precursor availability during MAO-B inhibitor therapy.

Mechanism. Tryptophan conversion to serotonin can add to serotonergic toxicity risk if monoamine breakdown is impaired.

Recommendation. Avoid L-Tryptophan supplements with rasagiline.

Stack Score

How it moves the number.

Effect on the composite score

If both L-Tryptophan and Rasagiline are in the same stack, this pair applies −25 to your Stack Score (per scored contraindication row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.